IT1283634B1 - Un metodo citofluorimetrico per la determinazione nel siero di anti- corpi anti-antigene tumorali - Google Patents

Un metodo citofluorimetrico per la determinazione nel siero di anti- corpi anti-antigene tumorali

Info

Publication number
IT1283634B1
IT1283634B1 IT96MI000943A ITMI960943A IT1283634B1 IT 1283634 B1 IT1283634 B1 IT 1283634B1 IT 96MI000943 A IT96MI000943 A IT 96MI000943A IT MI960943 A ITMI960943 A IT MI960943A IT 1283634 B1 IT1283634 B1 IT 1283634B1
Authority
IT
Italy
Prior art keywords
cytofluorimetric
serum
bodies
determination
tumor
Prior art date
Application number
IT96MI000943A
Other languages
English (en)
Inventor
Gianni Bussolati
Alberto Bartorelli
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of ITMI960943A0 publication Critical patent/ITMI960943A0/it
Priority to IT96MI000943A priority Critical patent/IT1283634B1/it
Priority to DK97923025T priority patent/DK0901632T3/da
Priority to JP09540489A priority patent/JP2000510589A/ja
Priority to ES97923025T priority patent/ES2185938T3/es
Priority to AT97923025T priority patent/ATE227027T1/de
Priority to PT97923025T priority patent/PT901632E/pt
Priority to PCT/EP1997/002363 priority patent/WO1997043648A1/en
Priority to EP97923025A priority patent/EP0901632B1/en
Priority to DE69716728T priority patent/DE69716728T2/de
Priority to AU28945/97A priority patent/AU2894597A/en
Publication of ITMI960943A1 publication Critical patent/ITMI960943A1/it
Application granted granted Critical
Publication of IT1283634B1 publication Critical patent/IT1283634B1/it

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Sampling And Sample Adjustment (AREA)
IT96MI000943A 1996-05-10 1996-05-10 Un metodo citofluorimetrico per la determinazione nel siero di anti- corpi anti-antigene tumorali IT1283634B1 (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT96MI000943A IT1283634B1 (it) 1996-05-10 1996-05-10 Un metodo citofluorimetrico per la determinazione nel siero di anti- corpi anti-antigene tumorali
AT97923025T ATE227027T1 (de) 1996-05-10 1997-05-08 Zytofluorometrisches verfahren zur bestimmung von antikörper gegen tumorantigene im serum
JP09540489A JP2000510589A (ja) 1996-05-10 1997-05-08 腫瘍抗原に対する抗体の血清中の測定のための細胞蛍光定量法
ES97923025T ES2185938T3 (es) 1996-05-10 1997-05-08 Procedimiento citofluorometrico para la deteccion en suero de anticuerpos dirigidos frente a antigenos tumorales.
DK97923025T DK0901632T3 (da) 1996-05-10 1997-05-08 Cytofluorometrisk fremgangsmåde til bestemmelsen i serum af antistoffer mod tumorantigener
PT97923025T PT901632E (pt) 1996-05-10 1997-05-08 Processo citofluorometrico para a determinacao no soro de anticorpos contra antigenios tumorais
PCT/EP1997/002363 WO1997043648A1 (en) 1996-05-10 1997-05-08 A cytofluorometric method for the determination in serum of antibodies against tumoral antigens
EP97923025A EP0901632B1 (en) 1996-05-10 1997-05-08 A cytofluorometric method for the determination in serum of antibodies against tumoral antigens
DE69716728T DE69716728T2 (de) 1996-05-10 1997-05-08 Zytofluorometrisches verfahren zur bestimmung von antikörper gegen tumorantigene im serum
AU28945/97A AU2894597A (en) 1996-05-10 1997-05-08 A cytofluorometric method for the determination in serum of antibodies against tumoral antigens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000943A IT1283634B1 (it) 1996-05-10 1996-05-10 Un metodo citofluorimetrico per la determinazione nel siero di anti- corpi anti-antigene tumorali

Publications (3)

Publication Number Publication Date
ITMI960943A0 ITMI960943A0 (it) 1996-05-10
ITMI960943A1 ITMI960943A1 (it) 1997-11-10
IT1283634B1 true IT1283634B1 (it) 1998-04-23

Family

ID=11374241

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI000943A IT1283634B1 (it) 1996-05-10 1996-05-10 Un metodo citofluorimetrico per la determinazione nel siero di anti- corpi anti-antigene tumorali

Country Status (10)

Country Link
EP (1) EP0901632B1 (it)
JP (1) JP2000510589A (it)
AT (1) ATE227027T1 (it)
AU (1) AU2894597A (it)
DE (1) DE69716728T2 (it)
DK (1) DK0901632T3 (it)
ES (1) ES2185938T3 (it)
IT (1) IT1283634B1 (it)
PT (1) PT901632E (it)
WO (1) WO1997043648A1 (it)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623620A (en) * 1983-08-02 1986-11-18 Stichting Vrienden Van De Stichting Dr. Karl Landsteiner Enucleated granulocytes, their preparation and use
IL100626A0 (en) * 1991-01-11 1992-09-06 Cryopharm Corp A method of forming dry cells,diagnostic panels containing the same and diagnostic methods utilizing the same
IT1276860B1 (it) * 1994-11-04 1997-11-03 Zetesis Spa Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione

Also Published As

Publication number Publication date
EP0901632A1 (en) 1999-03-17
JP2000510589A (ja) 2000-08-15
DK0901632T3 (da) 2003-03-03
ES2185938T3 (es) 2003-05-01
ATE227027T1 (de) 2002-11-15
ITMI960943A1 (it) 1997-11-10
ITMI960943A0 (it) 1996-05-10
PT901632E (pt) 2003-02-28
DE69716728T2 (de) 2003-03-20
DE69716728D1 (de) 2002-12-05
EP0901632B1 (en) 2002-10-30
AU2894597A (en) 1997-12-05
WO1997043648A1 (en) 1997-11-20

Similar Documents

Publication Publication Date Title
ES2124533T3 (es) Anticuerpos monoclonales inmunoestimulantes.
BR0208603A (pt) Marcadores de tumor para carcinoma de células renais
EP0914155A4 (en) PROSTATE SPECIFIC MEMBRANE ANTIGEN MONOCLONAL ANTIBODIES
FI842992A0 (fi) Immunologiskt definitionsfoerfarande.
ES2138102T3 (es) Procedimiento para la deteccion de antigeno urinario asociado a tumores.
MX9706311A (es) Antigeno de membrana especifico de prostata y usos para el mismo.
NO20001238D0 (no) Monoklonalt antistoff som induserer apoptose
EP1116029A4 (en) ANTIBODIES FOR APOPTOSEMARKER AND APPLICATION METHOD
ES2167590T3 (es) Metodo para diagnosticar enfermedades autoinmunes.
DE3586216D1 (de) Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
ES2136598T3 (es) Inmunoanalisis de deteccion de anticuerpos monoclonales contra los peptidos de activacion de protrombina y sus productos de degradacion.
GR3005971T3 (it)
ES8802406A1 (es) Un metodo para detectar el anticuerpo para el antigeno superficial de la hepatitis b de subtipona como divisional de la patente de invencion 545.205 del 15-7-85
DK0991945T3 (da) Fremgangsmåde til identifikation af tumor-antigener med antistoffer i serum
IT1283634B1 (it) Un metodo citofluorimetrico per la determinazione nel siero di anti- corpi anti-antigene tumorali
SE0100938D0 (sv) Rearranged squamous cell carcinoma antigen genes
FI980863A0 (fi) Foerfarande foer bestaemning av en drycks oeverskumningsfaktor
ATE260115T1 (de) Reduzierte fett-absorption durch anti-lipase antikörper
DK1295126T3 (da) Immunoanalysesystemer til påvisning af hepatitis C-virusantigen
DE3650635D1 (de) Monoklonale Antikörper
ES2019573T3 (es) Inmunoensayo para la deteccion de alfa-haloacetamidas.
PT825256E (pt) Celula hibrida e a sua utilizacao para a producao de um farmaco para a inducao de uma imunidade tumoral
ES2074707T3 (es) Anticuerpos monoclonales que distinguen entre proteinas naturales y proteinas con secuencias modificadas.
ATE263784T1 (de) Anti-megakaryozyten monoklonaler antikörper 97a6

Legal Events

Date Code Title Description
0001 Granted